nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0908	0.282	CbGbCtD
Paricalcitol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0613	0.19	CbGbCtD
Paricalcitol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0585	0.182	CbGbCtD
Paricalcitol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0522	0.162	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0306	0.095	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0289	0.0897	CbGbCtD
Paricalcitol—CYP24A1—Vitamin D (calciferol) metabolism—GC—chronic obstructive pulmonary disease	0.0274	0.134	CbGpPWpGaD
Paricalcitol—VDR—leg—chronic obstructive pulmonary disease	0.0231	0.296	CbGeAlD
Paricalcitol—CYP24A1—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0206	0.1	CbGpPWpGaD
Paricalcitol—VDR—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0172	0.0841	CbGpPWpGaD
Paricalcitol—UGT1A4—Arylamine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0112	0.0548	CbGpPWpGaD
Paricalcitol—UGT1A4—respiratory system—chronic obstructive pulmonary disease	0.0104	0.133	CbGeAlD
Paricalcitol—UGT1A4—Heme degradation—HMOX1—chronic obstructive pulmonary disease	0.00924	0.0451	CbGpPWpGaD
Paricalcitol—CYP24A1—bronchus—chronic obstructive pulmonary disease	0.00856	0.11	CbGeAlD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00791	0.0386	CbGpPWpGaD
Paricalcitol—CYP24A1—trachea—chronic obstructive pulmonary disease	0.00769	0.0986	CbGeAlD
Paricalcitol—Alfacalcidol—GC—chronic obstructive pulmonary disease	0.00623	0.358	CrCbGaD
Paricalcitol—VDR—respiratory system—chronic obstructive pulmonary disease	0.00573	0.0734	CbGeAlD
Paricalcitol—Calcitriol—GC—chronic obstructive pulmonary disease	0.00555	0.319	CrCbGaD
Paricalcitol—CYP24A1—lung—chronic obstructive pulmonary disease	0.00552	0.0708	CbGeAlD
Paricalcitol—VDR—connective tissue—chronic obstructive pulmonary disease	0.00504	0.0646	CbGeAlD
Paricalcitol—VDR—bronchus—chronic obstructive pulmonary disease	0.00472	0.0604	CbGeAlD
Paricalcitol—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00439	0.0214	CbGpPWpGaD
Paricalcitol—VDR—trachea—chronic obstructive pulmonary disease	0.00423	0.0543	CbGeAlD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00412	0.0201	CbGpPWpGaD
Paricalcitol—UGT1A4—Porphyrin metabolism—HMOX1—chronic obstructive pulmonary disease	0.00402	0.0196	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00388	0.019	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00351	0.0171	CbGpPWpGaD
Paricalcitol—Cholecalciferol—GC—chronic obstructive pulmonary disease	0.00336	0.194	CrCbGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00317	0.0155	CbGpPWpGaD
Paricalcitol—VDR—lung—chronic obstructive pulmonary disease	0.00304	0.039	CbGeAlD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.003	0.0146	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00294	0.0144	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00228	0.0111	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00223	0.0109	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.0022	0.0107	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.0022	0.0107	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00182	0.00889	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0018	0.00881	CbGpPWpGaD
Paricalcitol—Calcipotriol—MPO—chronic obstructive pulmonary disease	0.00169	0.0973	CrCbGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00162	0.0079	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00161	0.00787	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.0016	0.00781	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.0016	0.0078	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00159	0.00779	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00158	0.0077	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00156	0.00761	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.00148	0.00725	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00131	0.0064	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00131	0.0064	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00124	0.00603	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00115	0.00563	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00114	0.00557	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00114	0.00556	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00114	0.00555	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.00112	0.00549	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00109	0.00534	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00106	0.00519	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00104	0.00508	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.001	0.0049	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000985	0.00481	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000966	0.00472	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000959	0.00468	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—HDAC2—chronic obstructive pulmonary disease	0.000958	0.00468	CbGpPWpGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000958	0.00468	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000946	0.00462	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000922	0.0045	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000912	0.00445	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000885	0.00432	CbGpPWpGaD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000832	0.00406	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000811	0.00396	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.0008	0.0039	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000789	0.00385	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000766	0.00374	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000757	0.0037	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000756	0.00369	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000735	0.00359	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000729	0.00356	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000726	0.00355	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000725	0.00354	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000725	0.00354	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000719	0.00351	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000697	0.0034	CbGpPWpGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000696	0.0034	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000688	0.00336	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000687	0.00335	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000674	0.00329	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00067	0.00327	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000669	0.00327	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000642	0.00314	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000639	0.00312	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00063	0.00308	CbGpPWpGaD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000604	0.00295	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000587	0.00287	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00058	0.00283	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000579	0.00283	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00056	0.00274	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000557	0.00272	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00055	0.00269	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000549	0.00268	CbGpPWpGaD
Paricalcitol—Cholecalciferol—CYP1A1—chronic obstructive pulmonary disease	0.000548	0.0315	CrCbGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000506	0.00247	CbGpPWpGaD
Paricalcitol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00134	CcSEcCtD
Paricalcitol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00134	CcSEcCtD
Paricalcitol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00134	CcSEcCtD
Paricalcitol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00134	CcSEcCtD
Paricalcitol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00134	CcSEcCtD
Paricalcitol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00133	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00133	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00133	CcSEcCtD
Paricalcitol—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00133	CcSEcCtD
Paricalcitol—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00133	CcSEcCtD
Paricalcitol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00132	CcSEcCtD
Paricalcitol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00131	CcSEcCtD
Paricalcitol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00131	CcSEcCtD
Paricalcitol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00131	CcSEcCtD
Paricalcitol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00131	CcSEcCtD
Paricalcitol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00131	CcSEcCtD
Paricalcitol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00131	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00131	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000492	0.0013	CcSEcCtD
Paricalcitol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.0013	CcSEcCtD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000486	0.00237	CbGpPWpGaD
Paricalcitol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00129	CcSEcCtD
Paricalcitol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00129	CcSEcCtD
Paricalcitol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00128	CcSEcCtD
Paricalcitol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00128	CcSEcCtD
Paricalcitol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00128	CcSEcCtD
Paricalcitol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00127	CcSEcCtD
Paricalcitol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00127	CcSEcCtD
Paricalcitol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00127	CcSEcCtD
Paricalcitol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.00127	CcSEcCtD
Paricalcitol—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00126	CcSEcCtD
Paricalcitol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00126	CcSEcCtD
Paricalcitol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00126	CcSEcCtD
Paricalcitol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00126	CcSEcCtD
Paricalcitol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00126	CcSEcCtD
Paricalcitol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00126	CcSEcCtD
Paricalcitol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00125	CcSEcCtD
Paricalcitol—Infection—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00125	CcSEcCtD
Paricalcitol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00125	CcSEcCtD
Paricalcitol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00125	CcSEcCtD
Paricalcitol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00125	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—chronic obstructive pulmonary disease	0.000469	0.00229	CbGpPWpGaD
Paricalcitol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00124	CcSEcCtD
Paricalcitol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00124	CcSEcCtD
Paricalcitol—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00123	CcSEcCtD
Paricalcitol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00122	CcSEcCtD
Paricalcitol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00121	CcSEcCtD
Paricalcitol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00121	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000455	0.00222	CbGpPWpGaD
Paricalcitol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000454	0.0012	CcSEcCtD
Paricalcitol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.0012	CcSEcCtD
Paricalcitol—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.0012	CcSEcCtD
Paricalcitol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.0012	CcSEcCtD
Paricalcitol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0012	CcSEcCtD
Paricalcitol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00119	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000448	0.00219	CbGpPWpGaD
Paricalcitol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00118	CcSEcCtD
Paricalcitol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.00117	CcSEcCtD
Paricalcitol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00117	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00117	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00117	CcSEcCtD
Paricalcitol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00116	CcSEcCtD
Paricalcitol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00116	CcSEcCtD
Paricalcitol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00116	CcSEcCtD
Paricalcitol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00116	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00115	CcSEcCtD
Paricalcitol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00115	CcSEcCtD
Paricalcitol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00115	CcSEcCtD
Paricalcitol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00114	CcSEcCtD
Paricalcitol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00114	CcSEcCtD
Paricalcitol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00114	CcSEcCtD
Paricalcitol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00114	CcSEcCtD
Paricalcitol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00113	CcSEcCtD
Paricalcitol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00113	CcSEcCtD
Paricalcitol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00113	CcSEcCtD
Paricalcitol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00113	CcSEcCtD
Paricalcitol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00112	CcSEcCtD
Paricalcitol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.00112	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00111	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00111	CcSEcCtD
Paricalcitol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000419	0.00111	CcSEcCtD
Paricalcitol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00111	CcSEcCtD
Paricalcitol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00111	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00111	CcSEcCtD
Paricalcitol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.0011	CcSEcCtD
Paricalcitol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000415	0.0011	CcSEcCtD
Paricalcitol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.0011	CcSEcCtD
Paricalcitol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000415	0.0011	CcSEcCtD
Paricalcitol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.0011	CcSEcCtD
Paricalcitol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00109	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00109	CcSEcCtD
Paricalcitol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00109	CcSEcCtD
Paricalcitol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00108	CcSEcCtD
Paricalcitol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00108	CcSEcCtD
Paricalcitol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00108	CcSEcCtD
Paricalcitol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00107	CcSEcCtD
Paricalcitol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00107	CcSEcCtD
Paricalcitol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00107	CcSEcCtD
Paricalcitol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00106	CcSEcCtD
Paricalcitol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000401	0.00106	CcSEcCtD
Paricalcitol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00106	CcSEcCtD
Paricalcitol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00106	CcSEcCtD
Paricalcitol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.00106	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.0004	0.00195	CbGpPWpGaD
Paricalcitol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00106	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000398	0.00195	CbGpPWpGaD
Paricalcitol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00105	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00105	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00105	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00105	CcSEcCtD
Paricalcitol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00105	CcSEcCtD
Paricalcitol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00104	CcSEcCtD
Paricalcitol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00104	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00103	CcSEcCtD
Paricalcitol—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00103	CcSEcCtD
Paricalcitol—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00103	CcSEcCtD
Paricalcitol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00102	CcSEcCtD
Paricalcitol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00102	CcSEcCtD
Paricalcitol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00102	CcSEcCtD
Paricalcitol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00102	CcSEcCtD
Paricalcitol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00102	CcSEcCtD
Paricalcitol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00102	CcSEcCtD
Paricalcitol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00101	CcSEcCtD
Paricalcitol—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00038	0.00101	CcSEcCtD
Paricalcitol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00101	CcSEcCtD
Paricalcitol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.001	CcSEcCtD
Paricalcitol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.001	CcSEcCtD
Paricalcitol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000378	0.001	CcSEcCtD
Paricalcitol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.001	CcSEcCtD
Paricalcitol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.000999	CcSEcCtD
Paricalcitol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000376	0.000996	CcSEcCtD
Paricalcitol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000376	0.000996	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.000993	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000371	0.00181	CbGpPWpGaD
Paricalcitol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000979	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000368	0.0018	CbGpPWpGaD
Paricalcitol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.000965	CcSEcCtD
Paricalcitol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00096	CcSEcCtD
Paricalcitol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00096	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000361	0.00176	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000358	0.000948	CcSEcCtD
Paricalcitol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.000948	CcSEcCtD
Paricalcitol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.000947	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.00175	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00035	0.000928	CcSEcCtD
Paricalcitol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000348	0.000923	CcSEcCtD
Paricalcitol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.000923	CcSEcCtD
Paricalcitol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00091	CcSEcCtD
Paricalcitol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00091	CcSEcCtD
Paricalcitol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000341	0.000904	CcSEcCtD
Paricalcitol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000895	CcSEcCtD
Paricalcitol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.000891	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000336	0.00164	CbGpPWpGaD
Paricalcitol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00088	CcSEcCtD
Paricalcitol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00088	CcSEcCtD
Paricalcitol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.000876	CcSEcCtD
Paricalcitol—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00033	0.000873	CcSEcCtD
Paricalcitol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.000872	CcSEcCtD
Paricalcitol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000325	0.000862	CcSEcCtD
Paricalcitol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.000859	CcSEcCtD
Paricalcitol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000851	CcSEcCtD
Paricalcitol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000851	CcSEcCtD
Paricalcitol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000833	CcSEcCtD
Paricalcitol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000831	CcSEcCtD
Paricalcitol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00082	CcSEcCtD
Paricalcitol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.000818	CcSEcCtD
Paricalcitol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000309	0.000818	CcSEcCtD
Paricalcitol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.000811	CcSEcCtD
Paricalcitol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000306	0.000811	CcSEcCtD
Paricalcitol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00081	CcSEcCtD
Paricalcitol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00081	CcSEcCtD
Paricalcitol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.000806	CcSEcCtD
Paricalcitol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000304	0.000806	CcSEcCtD
Paricalcitol—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000805	CcSEcCtD
Paricalcitol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000803	CcSEcCtD
Paricalcitol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000801	CcSEcCtD
Paricalcitol—Rash—Montelukast—chronic obstructive pulmonary disease	0.0003	0.000794	CcSEcCtD
Paricalcitol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.000794	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.000792	CcSEcCtD
Paricalcitol—Depression—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000792	CcSEcCtD
Paricalcitol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000789	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000297	0.00145	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000295	0.00144	CbGpPWpGaD
Paricalcitol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00078	CcSEcCtD
Paricalcitol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.000772	CcSEcCtD
Paricalcitol—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00077	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—EGFR—chronic obstructive pulmonary disease	0.00029	0.00142	CbGpPWpGaD
Paricalcitol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.000767	CcSEcCtD
Paricalcitol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000766	CcSEcCtD
Paricalcitol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.000766	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00141	CbGpPWpGaD
Paricalcitol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000765	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GC—chronic obstructive pulmonary disease	0.000289	0.00141	CbGpPWpGaD
Paricalcitol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000288	0.000764	CcSEcCtD
Paricalcitol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.000764	CcSEcCtD
Paricalcitol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000761	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000285	0.00139	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00075	CcSEcCtD
Paricalcitol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000748	CcSEcCtD
Paricalcitol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000737	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000273	0.00133	CbGpPWpGaD
Paricalcitol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.000722	CcSEcCtD
Paricalcitol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000718	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000268	0.00131	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00131	CbGpPWpGaD
Paricalcitol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000264	0.0007	CcSEcCtD
Paricalcitol—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.000697	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00127	CbGpPWpGaD
Paricalcitol—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.000685	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.000674	CcSEcCtD
Paricalcitol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000666	CcSEcCtD
Paricalcitol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000647	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	0.000244	0.00119	CbGpPWpGaD
Paricalcitol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000644	CcSEcCtD
Paricalcitol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000637	CcSEcCtD
Paricalcitol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00063	CcSEcCtD
Paricalcitol—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00063	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000626	CcSEcCtD
Paricalcitol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000624	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.00114	CbGpPWpGaD
Paricalcitol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00062	CcSEcCtD
Paricalcitol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000596	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000576	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000574	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000573	CcSEcCtD
Paricalcitol—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00057	CcSEcCtD
Paricalcitol—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000567	CcSEcCtD
Paricalcitol—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000559	CcSEcCtD
Paricalcitol—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000557	CcSEcCtD
Paricalcitol—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000556	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00103	CbGpPWpGaD
Paricalcitol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000553	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000207	0.00101	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000545	CcSEcCtD
Paricalcitol—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000536	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000528	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000528	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000526	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000524	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000197	0.000963	CbGpPWpGaD
Paricalcitol—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000522	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000195	0.000952	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000513	CcSEcCtD
Paricalcitol—VDR—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000192	0.000937	CbGpPWpGaD
Paricalcitol—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000506	CcSEcCtD
Paricalcitol—Infection—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000503	CcSEcCtD
Paricalcitol—Shock—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000498	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000496	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000492	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000489	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000483	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000182	0.000888	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000182	0.000887	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000179	0.000873	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000178	0.000869	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000461	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000461	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000458	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000455	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.000831	CbGpPWpGaD
Paricalcitol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000446	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00044	CcSEcCtD
Paricalcitol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000439	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000439	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000436	CcSEcCtD
Paricalcitol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000436	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.000801	CbGpPWpGaD
Paricalcitol—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000433	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00077	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000417	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000414	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000414	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000156	0.000761	CbGpPWpGaD
Paricalcitol—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000402	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.0004	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.0004	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00015	0.000731	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000148	0.000723	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000142	0.000695	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000373	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000363	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000137	0.000668	CbGpPWpGaD
Paricalcitol—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000358	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000135	0.000659	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00064	CbGpPWpGaD
Paricalcitol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000346	CcSEcCtD
Paricalcitol—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000335	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000126	0.000614	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.000608	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.000599	CbGpPWpGaD
Paricalcitol—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000322	CcSEcCtD
Paricalcitol—Rash—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000319	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000319	CcSEcCtD
Paricalcitol—Headache—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000317	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.000582	CbGpPWpGaD
Paricalcitol—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000301	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000109	0.000534	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000108	0.000526	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.000507	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000102	0.0005	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.0001	0.000491	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.54e-05	0.000466	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.52e-05	0.000465	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.4e-05	0.000459	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.04e-05	0.000441	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.92e-05	0.000435	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.74e-05	0.000427	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.1e-05	0.000395	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.75e-05	0.000378	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.27e-05	0.000355	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.47e-05	0.000316	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.19e-05	0.000302	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.82e-05	0.000235	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.69e-05	0.000229	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.36e-05	0.000213	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.56e-05	0.000125	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.53e-05	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000113	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000104	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.77e-05	8.67e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	8.55e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	7.96e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	7.55e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	5.13e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	4.91e-05	CbGpPWpGaD
